Targeting NF-κB with Nanotherapy in a Mouse Model of Adult T-Cell Leukemia/Lymphoma
Adult T-cell leukemia/lymphoma (ATLL) is an aggressive, clonal malignancy of mature T cells caused by human T-cell leukemia virus type 1. Although it is a rare tumor type, it serves as an excellent model of a virus driven process that transforms cells and engenders a highly malignant tumor that is e...
Main Authors: | Daniel A. Rauch, John C. Harding, Lee Ratner, Samuel A. Wickline, Hua Pan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Nanomaterials |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-4991/11/6/1582 |
Similar Items
-
NF-κB in Hematological Malignancies
by: Véronique Imbert, et al.
Published: (2017-05-01) -
NF-κB in T-cell Acute Lymphoblastic Leukemia: Oncogenic Functions in Leukemic and in Microenvironmental Cells
by: Mónica T. Fernandes, et al.
Published: (2010-11-01) -
Novel Mutations in a Lethal Case of Lymphomatous Adult T Cell Lymphoma with Cryptic Myocardial Involvement
by: Taraneh Hashemi Zonouz, et al.
Published: (2021-02-01) -
Interplay between proteasome inhibitors and NF-κB pathway in leukemia and lymphoma: a comprehensive review on challenges ahead of proteasome inhibitors
by: Mahdi Pakjoo, et al.
Published: (2024-02-01) -
Adult T-Cell Leukemia-Lymphoma Presenting Concurrently with Myelopathy
by: Sneha Poondru, et al.
Published: (2022-11-01)